{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:41:30Z","timestamp":1761864090914,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2018YFC2001600, 2018YFC2001602, 2017YFC0108000"],"award-info":[{"award-number":["2018YFC2001600, 2018YFC2001602, 2017YFC0108000"]}]},{"name":"National Nature Science Foundation of China grants","award":["61901214, 81771940"],"award-info":[{"award-number":["61901214, 81771940"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["NJ2019010"],"award-info":[{"award-number":["NJ2019010"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Biol Eng Comput"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11517-020-02164-2","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T14:02:45Z","timestamp":1585576965000},"page":"1285-1295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunohistochemical index prediction of breast tumor based on multi-dimension features in contrast-enhanced ultrasound"],"prefix":"10.1007","volume":"58","author":[{"given":"Fang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"2164_CR1","unstructured":"Siegel R, Jemal A (2013) Breast cancer facts and figures 2013-2014. In: American Cancer Society. 1(3): 1\u201338"},{"issue":"12","key":"2164_CR2","first-page":"1212","volume":"16","author":"BW Davis","year":"1986","unstructured":"Davis BW, Gelber RD, Goldhirsch A et al (1986) Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer 16(12):1212\u20131218","journal-title":"Cancer"},{"issue":"34","key":"2164_CR3","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1200\/JCO.2009.23.2025","volume":"27","author":"AM Gonzalezangulo","year":"2009","unstructured":"Gonzalezangulo AM, Litton JK, Broglio KR et al (2009) High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol 27(34):5700\u20135706","journal-title":"J Clin Oncol"},{"key":"2164_CR4","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/jcp.2006.045377","volume":"60","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, Ellis IO (2007) An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol 60:1300\u20131306","journal-title":"J Clin Pathol"},{"key":"2164_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/jcp.54.1.20","volume":"54","author":"H Denley","year":"2001","unstructured":"Denley H, Pinder SE, Elston CW, Lee AH, Ellis IO (2001) Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol 54:20\u201324","journal-title":"J Clin Pathol"},{"key":"2164_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1634\/theoncologist.1-1-8","volume":"1","author":"V Valero","year":"1996","unstructured":"Valero V, Buzdar AU, Hortobagyi GN (1996) Locally advanced breast cancer. Oncologist 1:8\u201317","journal-title":"Oncologist"},{"issue":"2","key":"2164_CR7","first-page":"337","volume":"14","author":"S Umemura","year":"2005","unstructured":"Umemura S, Takekoshi S, Suzuki Y, Saitoh Y, Tokuda Y, Osamura RY (2005) Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.[J]. Oncol Rep 14(2):337\u2013343","journal-title":"Oncol Rep"},{"issue":"33","key":"2164_CR8","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1200\/JCO.2009.23.8089","volume":"27","author":"J Cortes","year":"2009","unstructured":"Cortes J, Baselga J (2009) How to treat hormone receptor-positive, human epidermal growth factor receptor 2-amplified breast cancer. J Clin Oncol 27(33):5492\u20135494","journal-title":"J Clin Oncol"},{"issue":"9","key":"2164_CR9","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/cncr.23350","volume":"112","author":"S Dawood","year":"2010","unstructured":"Dawood S, Kristine Broglio MS, Yun GM et al (2010) Prognostic significance of HER-2 status in women with inflammatory breast cancer. Cancer 112(9):1905\u20131911","journal-title":"Cancer"},{"key":"2164_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10147-006-0575-4","volume":"11","author":"E Tokunaga","year":"2006","unstructured":"Tokunaga E, Oki E, Nishida K, Koga T, Egashira A, Morita M, Kakeji Y, Maehara Y (2006) Trastuzumab and breast cancer: developments and current status. Int J Clin Oncol 11:199\u2013208","journal-title":"Int J Clin Oncol"},{"key":"2164_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1074\/mcp.R400001-MCP200","volume":"3","author":"JS Ross","year":"2004","unstructured":"Ross JS, Fletcher JA, Bloom KJ, Linette GP, Stec J, SymmansWF et al (2004) Targeted therapy in breast cancer: the HER-2\/ neu gene and protein. Mol Cell Proteomics 3:379\u2013398","journal-title":"Mol Cell Proteomics"},{"key":"2164_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ctrv.2008.09.003","volume":"35","author":"DL Nielsen","year":"2008","unstructured":"Nielsen DL, Andersson M, Kamby C (2008) HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors. Cancer Treat Rev 35:121\u2013136","journal-title":"Cancer Treat Rev"},{"key":"2164_CR13","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","volume":"26","author":"PL Nguyen","year":"2008","unstructured":"Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373\u20132378","journal-title":"J Clin Oncol"},{"issue":"default","key":"2164_CR14","first-page":"289","volume":"2009","author":"CG Murphy","year":"2009","unstructured":"Murphy CG, Modi S (2009) HER2 breast cancer therapies: a review. Biologics Targets Ther 2009(default):289","journal-title":"Biologics Targets Ther"},{"issue":"2","key":"2164_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1309\/99AE032R9FM8WND1","volume":"129","author":"DG Hicks","year":"2008","unstructured":"Hicks DG, Kulkarni S (2008) HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools. Am J Clin Pathol 129(2):263\u2013273","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2164_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10549-011-1862-y","volume":"131","author":"G Rocque","year":"2012","unstructured":"Rocque G, Onitilo A, Engel J et al (2012) Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. Breast Cancer Res Treat 131(2):713\u2013721","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"2164_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/mp.56.6.323","volume":"56","author":"I Guerra","year":"2003","unstructured":"Guerra I, Algorta J, De Otazu RD et al (2003) Immunohistochemical prognostic index for breast cancer in young women. Mol Pathol 56(6):323\u2013327","journal-title":"Mol Pathol"},{"issue":"1","key":"2164_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3233\/BD-2006-23103","volume":"23","author":"N Klauber-DeMore","year":"2006","unstructured":"Klauber-DeMore N (2006) Tumor biology of breast cancer in young women. Breast Dis 23(1):9\u201315","journal-title":"Breast Dis"},{"issue":"1","key":"2164_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/sj.bjc.6602256","volume":"92","author":"RJ Burcombe","year":"2005","unstructured":"Burcombe RJ, Makris A, Richman PI, Daley FM, Noble S, Pittam M, Wright D, Allen SA, Dove J, Wilson GD (2005) Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer 92(1):147\u2013155","journal-title":"Br J Cancer"},{"issue":"1","key":"2164_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejrad.2008.07.037","volume":"69","author":"C Balleyguier","year":"2009","unstructured":"Balleyguier C, Opolon P, Mathieu MC, Athanasiou A, Garbay JR, Delaloge S, Dromain C (2009) New potential and applications of contrast-enhanced ultrasound of the breast: own investigations and review of the literature. Eur J Radiol 69(1):14\u201323","journal-title":"Eur J Radiol"},{"issue":"2","key":"2164_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4048\/jbc.2013.16.2.208","volume":"16","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Jiang Q, Zhang Y et al (2013) Diagnostic value of contrast-enhanced ultrasound parametric imaging in breast tumors. J Breast Cancer 16(2):208","journal-title":"J Breast Cancer"},{"issue":"1","key":"2164_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0284185113517115","volume":"56","author":"Q Hu","year":"2015","unstructured":"Hu Q, Wang XY, Zhu SY, Kang LK, Xiao YJ, Zheng HY (2015) Meta-analysis of contrast-enhanced ultrasound for the differentiation of benign and malignant breast lesions. Acta Radiol 56(1):25\u201333","journal-title":"Acta Radiol"},{"issue":"11","key":"2164_CR23","first-page":"11957","volume":"11","author":"Z Cai","year":"2018","unstructured":"Cai Z, Li M, Zhang Y et al (2018) Values of contrast-enhanced ultrasound combined with BI-RADS in differentiating benign and malignant breast lesions. Int J Clin Exp Med 11(11):11957\u201311964","journal-title":"Int J Clin Exp Med"},{"key":"2164_CR24","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.ultrasmedbio.2019.07.551","volume":"45","author":"K Kamei","year":"2019","unstructured":"Kamei K, Kaneoka Y, Harada T et al (2019) Investigation of contrast-enhanced ultrasound findings for the differential diagnosis of small breast lesions. Ultrasound Med Biol 45:S43","journal-title":"Ultrasound Med Biol"},{"issue":"8","key":"2164_CR25","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.ultrasmedbio.2018.03.015","volume":"44","author":"B Theek","year":"2018","unstructured":"Theek B, Opacic T, Lammers T, Kiessling F (2018) Semi-automated segmentation of the tumor vasculature in contrast-enhanced ultrasound data. Ultrasound Med Biol 44(8):1910\u20131917","journal-title":"Ultrasound Med Biol"},{"key":"2164_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2214\/AJR.12.8781","volume":"200","author":"A Irshad","year":"2013","unstructured":"Irshad A, Leddy R, Pisano E, Baker N, Lewis M, Ackerman S, Campbell A (2013) Assessing the role of ultrasound in predicting the biological behavior of breast cancer. AJR Am J Roentgenol 200:284\u2013290","journal-title":"AJR Am J Roentgenol"},{"key":"2164_CR27","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1038\/srep11085","volume":"5","author":"L Zhang","year":"2015","unstructured":"Zhang L, Li J, Xiao Y et al (2015) Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision. Sci Rep 5:11085","journal-title":"Sci Rep"},{"key":"2164_CR28","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"TCN Co","year":"2014","unstructured":"Co TCN, Aerts HJWL, Velazquez ER, Leijenaar RTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach[J]. Nat Commun 5:4006","journal-title":"Nat Commun"},{"issue":"1","key":"2164_CR29","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1038\/s41598-018-29653-7","volume":"8","author":"B Theek","year":"2018","unstructured":"Theek B, Opacic T, Magnuska Z, Lammers T, Kiessling F (2018) Radiomic analysis of contrast-enhanced ultrasound data[J]. Sci Rep 8(1):11359","journal-title":"Sci Rep"},{"issue":"5","key":"2164_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00330-009-1656-3","volume":"20","author":"K Eun","year":"2010","unstructured":"Eun K, Byung L, Hyuna K et al (2010) Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol 20(5):1111\u20131117","journal-title":"Eur Radiol"},{"issue":"3","key":"2164_CR31","first-page":"146","volume":"18","author":"Y Kojima","year":"2015","unstructured":"Kojima Y, Tsunoda H (2015) Mammography and ultrasound features of triple-negative breast cancer[J]. Radiol Pract 18(3):146\u2013151","journal-title":"Radiol Pract"},{"issue":"2","key":"2164_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2214\/AJR.10.6096","volume":"199","author":"K Krizmanichconniff","year":"2012","unstructured":"Krizmanichconniff K, Paramagul C, Patterson SK et al (2012) Triple negative breast cancer: imaging and clinical characteristics. AJR Am J Roentgenol 199(2):458\u2013464","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"2164_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1258\/ar.2012.110562","volume":"53","author":"A Saracco","year":"2012","unstructured":"Saracco A, Szab\u00f3 BK, Aspelin P, Leifland K, Wilczek B, Celebioglu F, Axelsson R (2012) Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound[J]. Acta Radiol 53(4):382\u2013388","journal-title":"Acta Radiol"},{"issue":"10","key":"2164_CR34","first-page":"6985","volume":"7","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zhou Q, Liu J, Tang S, Liang X, Zhou Z, He Y, Peng H, Xiao Y (2014) Tumor size of breast invasive ductal cancer measured with contrast-enhanced ultrasound predicts regional lymph node metastasis and N stage. Int J Clin Exp Pathol 7(10):6985\u20136991","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2164_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejrad.2015.10.017","volume":"85","author":"YM Wang","year":"2016","unstructured":"Wang YM, Fan W, Zhao S et al (2016) Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound. Eur J Radiol 85(1):48\u201354","journal-title":"Eur J Radiol"},{"issue":"10","key":"2164_CR36","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1007\/s00330-009-1418-2","volume":"19","author":"ITH Au-Yong","year":"2009","unstructured":"Au-Yong ITH, Evans AJ, Taneja S et al (2009) Sonographic correlations with the new molecular classification of invasive breast cancer. Eur Radiol 19(10):2342\u20132348","journal-title":"Eur Radiol"},{"issue":"2","key":"2164_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12013-012-9346-1","volume":"63","author":"D Wenhua","year":"2012","unstructured":"Wenhua D, Lijia L, Hui W, Wei Y, Li T (2012) The clinical significance of real-time contrast-enhanced ultrasonography in the differential diagnosis of breast tumor. Cell Biochem Biophys 63(2):117\u2013120","journal-title":"Cell Biochem Biophys"},{"key":"2164_CR38","doi-asserted-by":"crossref","unstructured":"Hara K, Kataoka H, Satoh Y. Can spatiotemporal 3d cnns retrace the history of 2d cnns and imagenet?\/\/Proceedings of the IEEE conference on Computer Vision and Pattern Recognition. 2018:6546\u20136555","DOI":"10.1109\/CVPR.2018.00685"},{"issue":"5","key":"2164_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41591-018-0029-3","volume":"24","author":"DSW Ting","year":"2018","unstructured":"Ting DSW, Liu Y, Burlina P, Xu X, Bressler NM, Wong TY (2018) AI for medical imaging goes deep[J]. Nat Med 24(5):539\u2013540","journal-title":"Nat Med"},{"issue":"6","key":"2164_CR40","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00330-016-4628-4","volume":"27","author":"X Xiao","year":"2017","unstructured":"Xiao X, Jiang Q, Wu H et al (2017) Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound\u2014a preliminary study in China. Eur Radiol 27(6):2443\u20132450","journal-title":"Eur Radiol"},{"issue":"9","key":"2164_CR41","first-page":"15889","volume":"8","author":"X Leng","year":"2015","unstructured":"Leng X, Huang G, Yao L, Ma F (2015) Role of multi-mode ultrasound in the diagnosis of level 4 BI-RADS breast lesions and logistic regression model. Int J Clin Exp Med 8(9):15889\u201315899","journal-title":"Int J Clin Exp Med"}],"container-title":["Medical & Biological Engineering & Computing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-020-02164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11517-020-02164-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-020-02164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T23:29:01Z","timestamp":1617060541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11517-020-02164-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2164"],"URL":"https:\/\/doi.org\/10.1007\/s11517-020-02164-2","relation":{},"ISSN":["0140-0118","1741-0444"],"issn-type":[{"type":"print","value":"0140-0118"},{"type":"electronic","value":"1741-0444"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"17 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable (see Ethics approval).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}